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1. INTRODUCTION {#mc22752-sec-0002}
===============

Phosphoinositide 3‐kinases (PI3K) are a family of enzymes, first discovered in 1985 that have been classified into three groups.[1](#mc22752-bib-0001){ref-type="ref"} Class I PI3Ks are the best characterized and have been implicated in cancer given their role in various cellular processes including cell differentiation, metabolism, inflammation, cell motility, and cancer progression.[2](#mc22752-bib-0002){ref-type="ref"} The PI3Ks can be activated by an array of stimuli, including growth factors, cytokines, and hormones through various membrane receptors such as receptor tyrosine kinases (RTKs) that include *EGFR* (epidermal growth factor receptor) and *PDGFR* (platelet‐derived growth factor receptor).[3](#mc22752-bib-0003){ref-type="ref"} Downstream of PI3K, *AKT* (alias protein kinase B or PKB) is activated by PI3K. *AKT*, initially identified as a component of insulin intracellular signaling, is involved in the regulation of key factors related to cell growth, survival, and proliferation, including activation of mammalian target of rapamycin complex 1 (mTORC made up of *mTOR*, Raptor *mLST8*, and *PRAS40*)[4](#mc22752-bib-0004){ref-type="ref"}; ribosomal S6 kinases; pro‐apoptotic FOXO proteins; IKK which induces NFκB transcriptional activity; *CREB* (cAMP response element‐binding protein) a cellular transcription factor that influences cell survival; and *BAD* (Bcl‐2‐associated death promoter) involved in the initiation of apoptosis.[2](#mc22752-bib-0002){ref-type="ref"}, [5](#mc22752-bib-0005){ref-type="ref"}, [6](#mc22752-bib-0006){ref-type="ref"} *PTEN* (phosphatase and tensin homolog), a tumor suppressor gene, can inactivate this pathway and has been associated with multiple cancers and alterations in cell cycle regulation and apoptosis.[7](#mc22752-bib-0007){ref-type="ref"} We have shown that genetic variation in *PIK3CA* and *AKT1* is associated with a strong increased risk of colon cancer.[8](#mc22752-bib-0008){ref-type="ref"} Akt has been shown to be a key regulator in cell survival and proliferation.[9](#mc22752-bib-0009){ref-type="ref"} *PIK3CA*, the human gene encoding PI3K, also was importantly related to survival after diagnosis with colon cancer, suggesting that genetic variation in the PI3K/Akt pathway influences survival.[10](#mc22752-bib-0010){ref-type="ref"}

The PI3K/AKT signaling‐pathway is recognized as being one of the most frequently activated signal transduction pathways in cancer.[2](#mc22752-bib-0002){ref-type="ref"} MiRNAs can directly influence gene expression by binding to the 3\'un‐translated region (UTR) of the target mRNA and causing mRNA transcript degradation or repression of the target gene translation.[11](#mc22752-bib-0011){ref-type="ref"}, [12](#mc22752-bib-0012){ref-type="ref"} There is evidence that through these mechanisms miRNAs may influence genes that are central to the PI3K/Akt‐signaling pathway. Among the miRNAs reported to influence this pathway are miR‐133a, let‐7, miR‐21, miR‐205, miR‐200, miR‐130b, miR‐155, and miR‐106b.[13](#mc22752-bib-0013){ref-type="ref"}, [14](#mc22752-bib-0014){ref-type="ref"}

In this paper we ascertained 342 genes in the PI3K/Akt‐signaling pathway using Kyoto Encyclopedia of Genes and Genomes (KEGG) and evaluated 304 for which we have adequate expression data in our CRC samples. We identified genes in this pathway that are dysregulated in that the colorectal tumor mRNA expression levels are significantly different than mRNA expression in normal colorectal mucosa. For those genes that were dysregulated, we further evaluated their associations with expression levels of miRNAs. We hypothesized that genes in the PI3K/Akt‐signaling pathway are dysregulated in in colorectal cancer (CRC) and that miRNAs are linked to this dysregulation.

2. METHODS {#mc22752-sec-0003}
==========

2.1. Study participants {#mc22752-sec-0004}
-----------------------

Study participants come from two population‐based case‐control studies that included all incident colon and rectal cancer between 30 and 79 years of age in Utah or were members of Kaiser Permanente in Northern California (KPNC). Participants were non‐Hispanic white, Hispanic, or black for the colon cancer study; the rectal cancer study also included people of Asian race.[15](#mc22752-bib-0015){ref-type="ref"}, [16](#mc22752-bib-0016){ref-type="ref"} Case diagnosis was verified by tumor registry data as a first primary adenocarcinoma of the colon or rectum and were diagnosed between October 1991 and September 1994 (colon study) and between May 1997 and May 2001 (rectal study).[17](#mc22752-bib-0017){ref-type="ref"} The Institutional Review Boards at the University of Utah and at KPNC approved the study.

2.2. RNA processing {#mc22752-sec-0005}
-------------------

Formalin‐fixed paraffin embedded tissue from the initial biopsy or surgery was used to extract RNA. RNA was extracted, isolated, and purified from carcinoma tissue and adjacent normal mucosa as previously described.[18](#mc22752-bib-0018){ref-type="ref"} We observed no differences in RNA quality based on age of the tissue. The same RNA preparation was used to generate both the mRNA and miRNA data.

2.3. mRNA: RNA‐Seq sequencing library preparation and data processing {#mc22752-sec-0006}
---------------------------------------------------------------------

Total RNA from 245 colorectal carcinoma and normal mucosa pairs was chosen for sequencing based on availability of RNA and high quality miRNA data; 217 pairs passed quality control (QC) and were used in these analyses. RNA library construction was done with the Illumina TruSeq Stranded Total RNA Sample Preparation Kit with Ribo‐Zero. The samples were then fragmented and primed for cDNA synthesis, adapters were then ligated onto the cDNA, and the resulting samples were then amplified using PCR; the amplified library was then purified using Agencount AMPure XP beads. A more detailed description of the methods can be found in our previous work.[19](#mc22752-bib-0019){ref-type="ref"} Illumina TruSeq v3 single read flow cell and a 50 cycle single‐read sequence run was performed on an Illumina HiSeq instrument. Reads were aligned to a sequence database containing the human genome (build GRCh37/hg19, February 2009 from [genome.ucsc.edu](http://genome.ucsc.edu)) and alignment was performed using novoalign v2.08.01. Total gene counts were calculated for each exon and UTR of the genes using a list of gene coordinates obtained from <http://genome.ucsc.edu>. We disregarded genes that were not expressed in our RNA‐Seq data or for which the expression was missing for the majority of samples.[19](#mc22752-bib-0019){ref-type="ref"}

2.4. miRNA {#mc22752-sec-0007}
----------

The Agilent Human miRNA Microarray V19.0 was used. Data were required to pass stringent QC parameters established by Agilent that included tests for excessive background fluorescence, excessive variation among probe sequence replicates on the array, and measures of the total gene signal on the array to assess low signal. Samples failing to meet quality standards were re‐labeled, hybridized to arrays, and re‐scanned. If a sample failed QC assessment a second time, the sample was excluded from analysis. The repeatability associated with this microarray was extremely high (*r* = 0.98)[17](#mc22752-bib-0017){ref-type="ref"}; comparison of miRNA expression levels obtained from the Agilent microarray to those obtained from qPCR had an agreement of 100% in terms of directionality of findings and the FCs were almost identical.[20](#mc22752-bib-0020){ref-type="ref"} To normalize differences in miRNA expression that could be attributed to the array, amount of RNA, location on array, or factors that could erroneously influence miRNA expression levels, total gene signal was normalized by multiplying each sample by a scaling factor which was the median of the 75th percentiles of all the samples divided by the individual 75th percentile of each sample.[21](#mc22752-bib-0021){ref-type="ref"}

2.5. *PI3K/Akt*‐signaling genes {#mc22752-sec-0008}
-------------------------------

The Kyoto Encyclopedia of Genes and Genomes (KEGG) ([www.genome.jp/kegg-bin/show_pathway?hsa04151](http://www.genome.jp/kegg-bin/show_pathway?hsa04151)) pathway map for PI3K‐AKT‐signaling was used to identify genes associated with this pathway. Using this map, we identified 342 genes, 304 of which had sufficient expression in CRC tissue for inclusion in the study (Supplemental Table S1).

2.6. Statistical methods {#mc22752-sec-0009}
------------------------

We utilized a negative binomial mixed effects model in SAS (accounting for carcinoma/normal status as well as for subject effect) to determine genes in the PI3K/Akt‐signaling pathway that had a significant difference in expression between individually paired colorectal carcinoma and normal mucosa (ie, differentially expressed) and their related fold changes (FC). In this test we offset the overall exposure as the log expression of all identified protein‐coding genes (*n* = 17,461). The Benjamini and Hochberg[22](#mc22752-bib-0022){ref-type="ref"} procedure was used to control the false discovery rate (FDR) using a value of 0.05 or less. A FC greater than one indicates a positive differential expression (ie, up‐regulated in carcinoma), while a FC between zero and one indicates a negative differential expression (ie, down‐regulated in carcinoma). We calculated level of expression of each gene by dividing the total expression for that gene in an individual by the total expression of all protein‐coding genes per million transcripts (RPMPCG or reads per million protein‐coding genes). We focused on those genes with FC of \>1.50 or \<0.67 for analysis with differential miRNA expression as these levels of FC may have a greater biological significance than smaller FCs. There were 814 miRNAs expressed in greater than 20% of normal colorectal mucosa that were analyzed; differential expression was calculated using subject‐level paired data as the expression in the carcinoma tissue minus the expression in the normal mucosa. In these analyses, we fit a least squares linear regression model to the RPMPCG differential expression levels and miRNA differential expression levels. *P*‐values were generated using the bootstrap method by creating a distribution of 10 000 F statistics derived by resampling the residuals from the null hypothesis model of no association between gene expression and miRNA expression using the boot package in R. Linear models were adjusted for age and sex. Multiplicity adjustments for gene/miRNA associations were made at the gene level using the FDR by Benjamini and Hochberg.[22](#mc22752-bib-0022){ref-type="ref"}

2.7. Bioinformatics analysis {#mc22752-sec-0010}
----------------------------

We analyzed miRNAs and targeted mRNAs for seed region matches. The mRNA 3′ UTR FASTA as well as the seed region sequence of the associated miRNA were analyzed to determine seed region pairings between miRNA and mRNA. MiRNA seed regions were calculated as described in our previous work[23](#mc22752-bib-0023){ref-type="ref"}; we calculated and included seeds of six, seven, and eight nucleotides in length. A seed match between the miRNA and the mRNA would increase the likelihood that identified genes associated with a specific miRNA were more likely to have a direct association, especially if there was an inverse association, given a higher propensity for binding and thus mRNA degradation. As miRTarBase[24](#mc22752-bib-0024){ref-type="ref"} uses findings from many different investigations spanning across years and alignments, we used FASTA sequences generated from both GRCh37 and GRCh38 Homo sapiens alignments, using UCSC Table Browser (<https://genome.ucsc.edu/cgi-bin/hgTables>).[25](#mc22752-bib-0025){ref-type="ref"} We downloaded FASTA sequences that matched our Ensembl IDs and had a consensus coding sequences (CCDS) available. Analysis was done using scripts in R 3.2.3 and in perl 5.018002.

3. RESULTS {#mc22752-sec-0011}
==========

Of the 217 study participants, 169 had been diagnosed with colon cancer, 118 were male, and 161 were non‐Hispanic white (Table [1](#mc22752-tbl-0001){ref-type="table-wrap"}). The mean age of the study population was 64.8 years. The majority of study participants (55.6%) were diagnosed at either AJCC Stage 1 or 2. *TP53* mutations were the most common tumor molecular phenotype of cases (47.5%) and *BRAF*‐mutated tumors were the least common tumor molecular phenotype observed (10.1%).

###### 

Description of Study Population

                       *N*    \%
  -------------------- ------ ------
  Site                        
  Colon                169    77.9
  Rectal               48     22.1
  Sex                         
  Male                 118    54.4
  Female               99     45.6
  Age                         
  Mean (SD)            64.8   10.1
  Race                        
  Non‐Hispanic White   161    74.2
  Hispanic             14     6.5
  Non‐Hispanic Black   8      3.7
  Unknown              34     15.7
  AJCC stage                  
  1                    58     27.1
  2                    61     28.5
  3                    72     33.6
  4                    23     10.8
  Tumor phenotype             
  *TP53* mutated       103    47.5
  *KRAS* mutated       69     31.8
  *BRAF* mutated       21     10.1
  CIMP high            45     20.7
  MSI                  29     13.4
  Vital status                
  Dead                 92     42.6
  Alive                124    57.4
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Of the 304 genes evaluated, 254 (83.6%) were statistically significantly dysregulated after adjustment for multiple comparisons. Of the 254 significantly dysregulated genes, 76 had a FC of \<0.67, and 57 had a FC of \>1.50 (Table [2](#mc22752-tbl-0002){ref-type="table-wrap"}) (Supplemental Table S2 lists expression results for all genes in the pathway). Among the most dysregulated genes (both up and down‐regulated) were genes involved in extracellular matrix (ECM) functions including collagen type genes (such as *COL4A6*, *COL4A4*, *COL2A1*, *COL4A3*, and *COL6A5*), tenascin genes (*TNC* and *TNXB*), thrombospondin genes (*THBS2*), and integrin subunit alpha and subunit beta genes. The cytokine‐related genes, *IL3RA*, *IL6R*, and *IL7R* were significantly down‐regulated. Several growth factor genes, including *IGF1*, *FGFR2*, *FGF9*, *FGF10*, *EGF*, and *PDGFD* were down‐regulated in CRC tumor tissue. *PIK3CG* and *PIK3CD* also were significantly down‐regulated (FC 0.40 and 0.59 respectively), which could influence down‐stream genes including *BRCA1*, *CCND1*, *MYC*, *BCL2*, and *CREB*. Figure [1](#mc22752-fig-0001){ref-type="fig"} highlights those genes that are down‐regulated (yellow) and up‐regulated (green) in the PI3K/Akt‐signaling pathway.

###### 

Statistically significant differentially expressed PI3K/AKT pathway genes whose fold change is \<0.67 or \>1.5

  Gene         Tumor mean   Normal mean   Fold change   *P*‐value   Adjusted *P*‐value
  ------------ ------------ ------------- ------------- ----------- --------------------
  *TCL1A*      0.19         3.21          0.06          1.46E‐18    5.40E‐18
  *PCK1*       42.44        305.32        0.14          1.11E‐46    1.98E‐45
  *GNG7*       3.66         22.76         0.16          2.58E‐49    5.59E‐48
  *TNXB*       23.48        134.34        0.17          1.24E‐63    1.26E‐61
  *FGF9*       1.66         9.08          0.18          4.27E‐30    3.17E‐29
  *COL4A6*     3.80         16.61         0.23          1.94E‐37    2.10E‐36
  *COL6A5*     0.97         3.97          0.24          1.34E‐13    3.85E‐13
  *CREB3L3*    0.69         2.76          0.25          1.88E‐10    4.22E‐10
  *IL6R*       25.93        101.24        0.26          2.77E‐58    1.40E‐56
  *ITGA8*      9.84         37.30         0.26          2.42E‐46    4.09E‐45
  *COL4A5*     10.70        40.45         0.26          4.50E‐25    2.21E‐24
  *NGFR*       2.10         7.67          0.27          9.76E‐26    5.30E‐25
  *LPAR1*      12.91        46.29         0.28          6.42E‐52    1.63E‐50
  *COL4A4*     13.58        47.42         0.29          6.88E‐33    5.98E‐32
  *PDGFD*      5.90         19.58         0.30          8.17E‐28    5.10E‐27
  *TNR*        0.53         1.75          0.30          4.45E‐11    1.06E‐10
  *FIGF*       0.36         1.14          0.31          4.89E‐08    9.23E‐08
  *CHRM1*      1.10         3.43          0.32          4.01E‐12    1.03E‐11
  *GHR*        6.68         20.21         0.33          3.79E‐30    2.88E‐29
  *PIK3R6*     3.89         11.43         0.34          1.35E‐26    8.02E‐26
  *G6PC*       0.25         0.74          0.34          8.92E‐04    1.27E‐03
  *COL2A1*     1.47         4.17          0.35          6.37E‐11    1.49E‐10
  *G6PC2*      0.33         0.92          0.36          1.63E‐04    2.52E‐04
  *IGF1*       13.85        38.80         0.36          5.43E‐28    3.59E‐27
  *RELN*       5.68         15.85         0.36          8.90E‐18    3.15E‐17
  *SGK1*       50.97        137.98        0.37          4.36E‐38    5.10E‐37
  *EIF4E1B*    0.16         0.42          0.38          7.63E‐03    9.81E‐03
  *FGFR2*      26.51        68.82         0.39          2.32E‐21    9.93E‐21
  *COL4A3*     12.26        31.40         0.39          1.96E‐23    8.77E‐23
  *BCL2*       24.42        62.11         0.39          3.73E‐39    4.72E‐38
  *GYS2*       0.23         0.58          0.40          5.32E‐04    7.82E‐04
  *PIK3CG*     13.99        35.04         0.40          4.52E‐28    3.06E‐27
  *CHAD*       8.65         21.44         0.40          2.76E‐25    1.42E‐24
  *PRKAA2*     8.33         20.32         0.41          1.41E‐08    2.84E‐08
  *EFNA5*      10.41        25.33         0.41          2.50E‐15    7.92E‐15
  *FGF10*      1.70         4.06          0.42          1.85E‐10    4.21E‐10
  *KIT*        14.58        33.84         0.43          6.08E‐17    2.10E‐16
  *LAMC3*      4.06         9.43          0.43          2.41E‐14    7.17E‐14
  *IL7R*       35.03        79.98         0.44          8.00E‐29    5.65E‐28
  *EGF*        2.83         6.34          0.45          1.71E‐05    2.87E‐05
  *PPP2R3A*    28.10        62.55         0.45          3.67E‐37    3.84E‐36
  *PPP2R2B*    1.72         3.78          0.46          9.70E‐10    2.12E‐09
  *GNG2*       13.93        29.33         0.47          4.15E‐24    1.91E‐23
  *GNGT2*      0.71         1.46          0.49          1.10E‐05    1.87E‐05
  *CREB3L1*    96.13        195.06        0.49          1.51E‐16    5.15E‐16
  *CD19*       3.78         7.59          0.50          2.65E‐08    5.17E‐08
  *ITGA4*      36.27        71.10         0.51          1.71E‐25    8.99E‐25
  *FGFR3*      36.15        70.78         0.51          1.13E‐18    4.28E‐18
  *ITGB7*      11.13        21.51         0.52          6.05E‐18    2.17E‐17
  *GNGT1*      0.48         0.91          0.53          2.33E‐03    3.15E‐03
  *PDGFRA*     88.47        166.61        0.53          5.08E‐26    2.81E‐25
  *COL9A2*     26.53        49.91         0.53          4.06E‐12    1.03E‐11
  *LAMB4*      0.79         1.47          0.54          2.64E‐04    4.05E‐04
  *CHRM2*      2.32         4.20          0.55          1.89E‐03    2.61E‐03
  *PHLPP2*     79.32        139.85        0.57          1.77E‐28    1.22E‐27
  *FGF2*       10.04        17.66         0.57          2.79E‐13    7.86E‐13
  *TEK*        8.92         15.47         0.58          5.93E‐12    1.49E‐11
  *LPAR4*      0.40         0.68          0.58          2.33E‐02    2.87E‐02
  *FGF13*      2.42         4.18          0.58          2.84E‐05    4.69E‐05
  *PIK3CD*     27.33        46.48         0.59          9.96E‐22    4.33E‐21
  *CSF1*       28.49        47.90         0.59          3.95E‐21    1.67E‐20
  *FGF7*       8.17         13.70         0.60          1.49E‐08    2.97E‐08
  *ITGA7*      21.33        35.69         0.60          1.74E‐16    5.89E‐16
  *LPAR3*      1.36         2.26          0.60          1.41E‐03    1.98E‐03
  *IL3RA*      2.21         3.59          0.62          2.82E‐03    3.80E‐03
  *ITGA2B*     0.54         0.86          0.62          9.90E‐03    1.26E‐02
  *CSF3*       1.03         1.66          0.62          8.63E‐03    1.10E‐02
  *EPOR*       6.81         10.87         0.63          2.99E‐08    5.72E‐08
  *NR4A1*      201.17       319.66        0.63          5.51E‐11    1.31E‐10
  *EFNA2*      5.04         8.00          0.63          1.35E‐06    2.42E‐06
  *FASLG*      1.07         1.70          0.63          4.96E‐03    6.48E‐03
  *BCL2L11*    56.19        88.47         0.64          1.23E‐23    5.58E‐23
  *LPAR5*      25.37        39.84         0.64          5.44E‐20    2.15E‐19
  *SGK2*       42.18        65.06         0.65          1.12E‐09    2.42E‐09
  *PHLPP1*     42.56        65.01         0.65          1.03E‐20    4.16E‐20
  *THBS1*      585.51       881.12        0.66          3.69E‐18    1.34E‐17
  *NOS3*       23.67        15.66         1.51          1.27E‐09    2.72E‐09
  *PDGFC*      28.55        18.83         1.52          1.45E‐09    3.08E‐09
  *YWHAE*      214.66       141.14        1.52          8.22E‐28    5.10E‐27
  *ITGB8*      74.17        47.90         1.55          1.88E‐15    6.02E‐15
  *YWHAH*      102.59       66.00         1.55          1.54E‐25    8.22E‐25
  *EIF4B*      299.92       192.20        1.56          1.47E‐39    1.94E‐38
  *LAMA5*      242.34       155.24        1.56          3.52E‐14    1.03E‐13
  *ITGB1*      328.08       209.70        1.56          2.06E‐34    1.90E‐33
  *EFNA4*      15.36        9.82          1.57          1.17E‐14    3.55E‐14
  *GNG10*      6.37         4.00          1.59          2.92E‐08    5.62E‐08
  *CCND2*      773.45       483.06        1.60          3.23E‐16    1.08E‐15
  *ITGB5*      110.37       68.02         1.62          4.02E‐23    1.77E‐22
  *COL6A3*     893.58       541.26        1.65          2.92E‐18    1.07E‐17
  *VEGFA*      532.25       316.77        1.68          5.74E‐32    4.71E‐31
  *ITGAV*      191.03       113.43        1.68          2.91E‐30    2.27E‐29
  *TNC*        156.39       92.44         1.69          7.51E‐11    1.73E‐10
  *FGF1*       4.77         2.79          1.71          9.30E‐06    1.59E‐05
  *CDK6*       289.15       166.12        1.74          1.71E‐35    1.63E‐34
  *YWHAB*      389.26       223.04        1.75          1.32E‐37    1.49E‐36
  *TP53*       105.07       59.63         1.76          3.25E‐24    1.54E‐23
  *RHEB*       46.51        26.01         1.79          1.22E‐30    9.79E‐30
  *PPP2R3B*    4.34         2.42          1.79          1.09E‐08    2.20E‐08
  *YWHAQ*      130.47       72.74         1.79          8.52E‐37    8.63E‐36
  *CCNE1*      8.70         4.80          1.81          2.93E‐10    6.49E‐10
  *CDK2*       45.70        24.96         1.83          8.37E‐33    7.07E‐32
  *PDGFRB*     166.24       87.76         1.89          8.03E‐28    5.10E‐27
  *RPS6*       850.00       447.37        1.90          5.64E‐45    9.02E‐44
  *LAMC2*      138.11       70.95         1.95          3.56E‐24    1.67E‐23
  *DDIT4*      66.29        32.77         2.02          3.01E‐25    1.53E‐24
  *YWHAG*      241.75       119.30        2.03          1.69E‐52    4.68E‐51
  *F2R*        51.19        25.16         2.03          2.84E‐26    1.63E‐25
  *COL4A1*     509.38       243.49        2.09          1.17E‐43    1.78E‐42
  *FGF18*      1.90         0.85          2.22          1.27E‐05    2.14E‐05
  *BCL2L1*     144.28       64.05         2.25          1.06E‐56    4.02E‐55
  *COL9A1*     10.41        4.59          2.27          3.34E‐09    6.90E‐09
  *EIF4EBP1*   20.83        8.84          2.36          3.54E‐25    1.76E‐24
  *COL9A3*     17.74        7.51          2.36          1.74E‐12    4.68E‐12
  *BRCA1*      87.46        35.35         2.47          2.77E‐41    3.83E‐40
  *CDK4*       66.65        26.90         2.48          9.86E‐58    4.28E‐56
  *ITGA2*      206.67       82.69         2.50          1.27E‐48    2.41E‐47
  *HSP90AA1*   627.50       246.84        2.54          7.12E‐59    4.33E‐57
  *CCND1*      317.79       122.64        2.59          1.53E‐59    1.16E‐57
  *FN1*        1461.37      554.51        2.64          8.52E‐34    7.62E‐33
  *HSP90AB1*   593.22       213.90        2.77          6.27E‐75    1.91E‐72
  *EFNA3*      24.98        8.69          2.88          5.14E‐29    3.72E‐28
  *OSM*        6.68         2.31          2.90          4.35E‐16    1.44E‐15
  *COL1A2*     1838.76      588.95        3.12          9.45E‐49    1.91E‐47
  *ITGA11*     64.23        19.89         3.23          1.31E‐36    1.29E‐35
  *MET*        302.60       84.88         3.56          1.25E‐68    1.89E‐66
  *MYC*        181.11       49.00         3.70          5.76E‐55    1.95E‐53
  *COL1A1*     3190.86      754.73        4.23          1.19E‐54    3.61E‐53
  *FGF20*      0.72         0.14          5.29          2.29E‐05    3.83E‐05
  *THBS2*      212.12       32.95         6.44          1.67E‐51    3.91E‐50
  *COMP*       9.53         1.45          6.57          8.75E‐20    3.41E‐19
  *GNG4*       35.42        4.39          8.07          2.36E‐38    2.87E‐37
  *FGF19*      1.39         0.15          9.42          6.08E‐13    1.68E‐12
  *SPP1*       38.03        3.28          11.60         5.67E‐42    8.21E‐41
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![Kegg PI3K/Akt‐Signaling pathway with highlighted dysregulated mRNA and their associated seed‐region matched miRNA. Bold items depict negative beta coefficient between miRNA and mRNA](MC-57-243-g001){#mc22752-fig-0001}

Differential mRNA expression of 47 of the 133 genes with a FC of \<0.67 or \>1.50 were associated with differential miRNA expression. Of these 47 genes, 36 genes had seed‐region matches with their associated miRNAs (Table [3](#mc22752-tbl-0003){ref-type="table-wrap"}). Of the 147 mRNA:miRNA associations with seed‐region matches, 26 were inversely associated meaning that mRNA was down‐regulated when the miRNA was up‐regulated or the mRNA was up‐regulated when the miRNA was down‐regulated, suggesting a greater likelihood of a direct effect. While some genes only had a seed‐region match with one miRNA, such as *IGF1*, *PHLPP2*, *SGK2*, *ITGA4*, *CDK4*, *THBS1*, *ITGA11*, *CREB3L1*, and *GNG2*, most had seed‐region matches with multiple miRNAs. *IL6R* had a seed‐region match with 11 miRNAs with the majority being inversely associated, *ITGA2* had a seed‐region match with 14 miRNAs, and *YWHAB* had a seed‐region match with 19 miRNAs. Several miRNAs had seed‐region matches with multiple genes: miR‐1246, miR‐21‐3p, miR‐21‐5p, miR‐23a‐3p, miR‐375, and miR‐934 with two genes; let‐7i‐5p, miR193b‐3p, miR‐196‐5p, miR‐19b‐3p, miR‐221‐3p, and miR‐24‐3p with three genes; miR‐106b‐5p, miR199a‐5p, miR‐199b‐5p, miR‐29b‐3p, miR‐3651, and miR‐501‐3p with four genes; miR‐145‐5p and miR‐93‐5p with five genes; miR‐199a‐3p, miR‐203a, and miR‐27a‐3p with six genes; miR‐150‐5p, miR‐214‐3p and miR‐650 with seven genes; miR‐17‐5p, miR‐20a‐5p, and miR‐20b‐5p with eight genes. Expression levels of all of the genes associated with miR‐203a expression were inversely associated, suggesting direct associations. Figure [1](#mc22752-fig-0001){ref-type="fig"} highlights the miRNAs with seed‐region matches associated with various components of the PI3K/Akt‐signaling pathway.

###### 

Associations between PI3K/AKT pathway genes with miRNAs that have a seed match

  Gene name                                              Tumor mean   Normal mean   Fold change   miRNA                 Tumor mean   Normal mean   Fold change   Beta    Raw *P*‐value   FDR *P*‐value
  ------------------------------------------------------ ------------ ------------- ------------- --------------------- ------------ ------------- ------------- ------- --------------- ---------------
  ***BRCA1*** [^a^](#mc22752-note-0001){ref-type="fn"}   87.46        35.35         2.47          hsa‐miR‐1246          629.21       412.81        1.52          0.25    0.0008          0.0383
                                                                                                  **hsa‐miR‐145‐5p**    132.97       223.14        0.60          −0.28   0.0004          0.025
                                                                                                  hsa‐miR‐17‐5p         61.04        16.38         3.73          0.28    \<0.0001        0.0116
                                                                                                  hsa‐miR‐20a‐5p        70.78        17.61         4.02          0.25    0.0006          0.0383
                                                                                                  hsa‐miR‐20b‐5p        17.65        3.30          5.35          0.25    0.0004          0.0326
                                                                                                  hsa‐miR‐93‐5p         41.72        15.20         2.74          0.30    \<0.0001        0.0116
  *IGF1*                                                 13.85        38.80         0.36          hsa‐miR‐145‐5p        132.97       223.14        0.60          0.28    \<0.0001        0.0407
  *PHLPP2*                                               79.32        139.85        0.57          hsa‐miR‐150‐5p        14.90        39.17         0.38          0.29    \<0.0001        0.0271
  *TNC*                                                  156.39       92.44         1.69          hsa‐miR‐199a‐5p       20.18        9.28          2.17          0.25    0.0002          0.0163
                                                                                                  hsa‐miR‐199b‐5p       4.69         1.53          3.07          0.27    0.0002          0.0203
  ***PHLPP1***                                           42.56        65.01         0.65          **hsa‐miR‐214‐3p**    13.24        6.13          2.16          −0.26   0.0002          0.0488
                                                                                                  **hsa‐miR‐663b**      65.50        32.21         2.03          −0.26   \<0.0001        0.0488
  *ITGB5*                                                110.37       68.02         1.62          hsa‐miR‐199a‐3p       44.83        22.53         1.99          0.32    \<0.0001        0.0163
                                                                                                  hsa‐miR‐199a‐5p       20.18        9.28          2.17          0.36    \<0.0001        0.0163
                                                                                                  hsa‐miR‐199b‐5p       4.69         1.53          3.07          0.28    0.0002          0.0233
                                                                                                  hsa‐miR‐24‐3p         106.75       62.39         1.71          0.25    0.0006          0.0444
  *SGK2*                                                 42.18        65.06         0.65          hsa‐miR‐196b‐5p       17.89        5.53          3.24          0.37    \<0.0001        0.0271
  ***PIK3CG***                                           13.99        35.04         0.40          **hsa‐miR‐203a**      12.52        3.70          3.38          −0.34   \<0.0001        0.0203
                                                                                                  hsa‐miR‐650           4.51         16.60         0.27          0.36    \<0.0001        0.0203
  *COL1A1*                                               3190.86      754.73        4.23          hsa‐miR‐199a‐5p       20.18        9.28          2.17          0.29    \<0.0001        0.0163
                                                                                                  hsa‐miR‐199b‐5p       4.69         1.53          3.07          0.30    \<0.0001        0.0163
                                                                                                  hsa‐miR‐214‐3p        13.24        6.13          2.16          0.34    \<0.0001        0.0163
                                                                                                  hsa‐miR‐934           4.36         0.94          4.66          0.58    \<0.0001        0.0163
  *CCND1*                                                317.79       122.64        2.59          hsa‐miR‐106b‐5p       15.90        5.19          3.06          0.25    0.0006          0.0349
                                                                                                  hsa‐miR‐17‐5p         61.04        16.38         3.73          0.30    \<0.0001        0.0244
                                                                                                  hsa‐miR‐19b‐3p        29.80        10.42         2.86          0.28    0.0003          0.0244
                                                                                                  hsa‐miR‐20a‐5p        70.78        17.61         4.02          0.28    \<0.0001        0.0244
                                                                                                  hsa‐miR‐20b‐5p        17.65        3.30          5.35          0.29    \<0.0001        0.0244
                                                                                                  hsa‐miR‐221‐3p        13.53        4.12          3.28          0.26    0.0003          0.0349
                                                                                                  hsa‐miR‐27a‐3p        56.26        23.29         2.42          0.27    0.0002          0.0244
                                                                                                  hsa‐miR‐29b‐3p        24.31        9.83          2.47          0.27    0.0003          0.0244
                                                                                                  hsa‐miR‐93‐5p         41.72        15.20         2.74          0.26    0.0002          0.0244
  *PDGFRB*                                               166.24       87.76         1.89          hsa‐miR‐193b‐3p       9.12         5.42          1.68          0.27    0.0002          0.0181
                                                                                                  hsa‐miR‐214‐3p        13.24        6.13          2.16          0.38    \<0.0001        0.0102
  ***ITGA4***                                            36.27        71.10         0.51          **hsa‐miR‐203a**      12.52        3.70          3.38          −0.30   \<0.0001        0.0116
  *YWHAQ*                                                130.47       72.74         1.79          hsa‐miR‐106b‐5p       15.90        5.19          3.06          0.29    \<0.0001        0.0116
                                                                                                  hsa‐miR‐17‐5p         61.04        16.38         3.73          0.30    \<0.0001        0.0116
                                                                                                  hsa‐miR‐20a‐5p        70.78        17.61         4.02          0.30    \<0.0001        0.0116
                                                                                                  hsa‐miR‐20b‐5p        17.65        3.30          5.35          0.31    \<0.0001        0.0116
                                                                                                  hsa‐miR‐27a‐3p        56.26        23.29         2.42          0.24    0.001           0.0471
                                                                                                  hsa‐miR‐425‐5p        11.76        6.97          1.69          0.23    0.0011          0.0471
                                                                                                  hsa‐miR‐93‐5p         41.72        15.20         2.74          0.33    \<0.0001        0.0116
  ***PDGFRA***                                           88.47        166.61        0.53          hsa‐miR‐145‐5p        132.97       223.14        0.60          0.26    0.0002          0.0163
                                                                                                  hsa‐miR‐150‐5p        14.90        39.17         0.38          0.24    0.0004          0.0233
                                                                                                  **hsa‐miR‐17‐5p**     61.04        16.38         3.73          −0.28   \<0.0001        0.0136
                                                                                                  **hsa‐miR‐19b‐3p**    29.80        10.42         2.86          −0.29   \<0.0001        0.0136
                                                                                                  **hsa‐miR‐203a**      12.52        3.70          3.38          −0.30   \<0.0001        0.0136
                                                                                                  **hsa‐miR‐20a‐5p**    70.78        17.61         4.02          −0.28   0.0002          0.0163
                                                                                                  **hsa‐miR‐20b‐5p**    17.65        3.30          5.35          −0.30   \<0.0001        0.0136
                                                                                                  **hsa‐miR‐29b‐3p**    24.31        9.83          2.47          −0.27   0.0003          0.0222
                                                                                                  **hsa‐miR‐501‐3p**    7.07         2.95          2.39          −0.25   0.0004          0.0233
                                                                                                  hsa‐miR‐650           4.51         16.60         0.27          0.32    \<0.0001        0.0136
  *CDK4*                                                 66.65        26.90         2.48          hsa‐miR‐3651          58.66        25.92         2.26          0.26    0.0003          0.0488
  *THBS1*                                                585.51       881.12        0.66          hsa‐miR‐145‐5p        132.97       223.14        0.60          0.29    \<0.0001        0.0407
  *ITGA11*                                               64.23        19.89         3.23          hsa‐miR‐193b‐3p       9.12         5.42          1.68          0.28    \<0.0001        0.0102
  ***ITGAV***                                            191.03       113.43        1.68          hsa‐let‐7i‐5p         62.16        39.97         1.56          0.31    0.0004          0.0271
                                                                                                  hsa‐miR‐199a‐3p       44.83        22.53         1.99          0.30    \<0.0001        0.0136
                                                                                                  hsa‐miR‐214‐3p        13.24        6.13          2.16          0.29    \<0.0001        0.0136
                                                                                                  hsa‐miR‐23a‐3p        174.68       87.53         2.00          0.27    0.0003          0.0244
                                                                                                  hsa‐miR‐27a‐3p        56.26        23.29         2.42          0.25    0.0012          0.0425
                                                                                                  **hsa‐miR‐6071**      0.97         1.70          0.57          −0.23   0.0011          0.0425
  *PDGFC*                                                28.55        18.83         1.52          hsa‐miR‐199b‐5p       4.69         1.53          3.07          0.28    0.0002          0.0488
                                                                                                  hsa‐miR‐934           4.36         0.94          4.66          0.27    \<0.0001        0.0407
  *CREB3L1*                                              96.13        195.06        0.49          **hsa‐miR‐196b‐5p**   17.89        5.53          3.24          −0.28   0.0002          0.0203
  ***IL6R***                                             25.93        101.24        0.26          hsa‐miR‐150‐5p        14.90        39.17         0.38          0.30    \<0.0001        0.0136
                                                                                                  **hsa‐miR‐17‐5p**     61.04        16.38         3.73          −0.24   0.0008          0.0362
                                                                                                  **hsa‐miR‐20a‐5p**    70.78        17.61         4.02          −0.24   0.0003          0.0163
                                                                                                  **hsa‐miR‐20b‐5p**    17.65        3.30          5.35          −0.29   0.0002          0.0136
                                                                                                  hsa‐miR‐2117          1.50         4.09          0.37          0.22    0.001           0.0388
                                                                                                  **hsa‐miR‐21‐5p**     463.11       167.37        2.77          −0.29   \<0.0001        0.0136
                                                                                                  **hsa‐miR‐23a‐3p**    174.68       87.53         2.00          −0.25   0.0007          0.0335
                                                                                                  **hsa‐miR‐27a‐3p**    56.26        23.29         2.42          −0.28   \<0.0001        0.0136
                                                                                                  **hsa‐miR‐3651**      58.66        25.92         2.26          −0.25   0.0003          0.0163
                                                                                                  hsa‐miR‐518c‐5p       1.76         2.90          0.61          0.22    0.0014          0.0475
                                                                                                  hsa‐miR‐650           4.51         16.60         0.27          0.29    0.0002          0.0136
  *COL6A3*                                               893.58       541.26        1.65          hsa‐let‐7i‐5p         62.16        39.97         1.56          0.26    \<0.0001        0.0081
                                                                                                  hsa‐miR‐214‐3p        13.24        6.13          2.16          0.43    \<0.0001        0.0081
  *ITGA2*                                                206.67       82.69         2.50          hsa‐miR‐106b‐5p       15.90        5.19          3.06          0.23    0.001           0.0339
                                                                                                  hsa‐miR‐10a‐5p        44.64        26.74         1.67          0.25    0.0006          0.0257
                                                                                                  hsa‐miR‐17‐5p         61.04        16.38         3.73          0.28    \<0.0001        0.0081
                                                                                                  hsa‐miR‐203a          12.52        3.70          3.38          0.34    \<0.0001        0.0081
                                                                                                  hsa‐miR‐20a‐5p        70.78        17.61         4.02          0.27    \<0.0001        0.0081
                                                                                                  hsa‐miR‐20b‐5p        17.65        3.30          5.35          0.33    \<0.0001        0.0081
                                                                                                  hsa‐miR‐21‐5p         463.11       167.37        2.77          0.28    0.0002          0.0116
                                                                                                  hsa‐miR‐221‐3p        13.53        4.12          3.28          0.37    \<0.0001        0.0081
                                                                                                  hsa‐miR‐24‐3p         106.75       62.39         1.71          0.23    0.0016          0.0432
                                                                                                  hsa‐miR‐29a‐3p        110.29       51.04         2.16          0.24    0.0006          0.0257
                                                                                                  hsa‐miR‐29b‐3p        24.31        9.83          2.47          0.22    0.0022          0.0497
                                                                                                  hsa‐miR‐3651          58.66        25.92         2.26          0.22    0.002           0.0479
                                                                                                  hsa‐miR‐501‐3p        7.07         2.95          2.39          0.26    0.0003          0.0163
                                                                                                  hsa‐miR‐93‐5p         41.72        15.20         2.74          0.26    0.0005          0.0239
  *COL1A2*                                               1838.76      588.95        3.12          hsa‐let‐7i‐5p         62.16        39.97         1.56          0.24    0.0002          0.0239
                                                                                                  hsa‐miR‐193b‐3p       9.12         5.42          1.68          0.29    \<0.0001        0.0148
                                                                                                  hsa‐miR‐199a‐3p       44.83        22.53         1.99          0.36    \<0.0001        0.0116
  ***YWHAB***                                            389.26       223.04        1.75          hsa‐miR‐106b‐5p       15.90        5.19          3.06          0.30    \<0.0001        0.0029
                                                                                                  hsa‐miR‐1246          629.21       412.81        1.52          0.24    0.0008          0.0099
                                                                                                  hsa‐miR‐130b‐3p       8.74         4.89          1.79          0.18    0.012           0.0485
                                                                                                  hsa‐miR‐17‐5p         61.04        16.38         3.73          0.44    \<0.0001        0.0029
                                                                                                  hsa‐miR‐196a‐5p       6.70         4.21          1.59          0.23    0.0007          0.0234
                                                                                                  hsa‐miR‐196b‐5p       17.89        5.53          3.24          0.39    \<0.0001        0.0095
                                                                                                  hsa‐miR‐199a‐3p       44.83        22.53         1.99          0.22    0.001           0.0029
                                                                                                  hsa‐miR‐19b‐3p        29.80        10.42         2.86          0.37    \<0.0001        0.0029
                                                                                                  hsa‐miR‐20a‐5p        70.78        17.61         4.02          0.45    \<0.0001        0.0029
                                                                                                  hsa‐miR‐20b‐5p        17.65        3.30          5.35          0.42    \<0.0001        0.0029
                                                                                                  hsa‐miR‐21‐3p         22.68        9.89          2.29          0.33    \<0.0001        0.0029
                                                                                                  hsa‐miR‐24‐3p         106.75       62.39         1.71          0.20    0.0067          0.035
                                                                                                  hsa‐miR‐27a‐3p        56.26        23.29         2.42          0.28    \<0.0001        0.0029
                                                                                                  hsa‐miR‐32‐3p         4.74         2.81          1.68          0.18    0.0115          0.0468
                                                                                                  hsa‐miR‐3651          58.66        25.92         2.26          0.29    \<0.0001        0.0029
                                                                                                  **hsa‐miR‐375**       20.50        54.53         0.38          −0.26   0.0002          0.0048
                                                                                                  hsa‐miR‐501‐3p        7.07         2.95          2.39          0.19    0.0078          0.0376
                                                                                                  **hsa‐miR‐6515‐5p**   1.20         4.41          0.27          −0.25   0.0005          0.0083
                                                                                                  hsa‐miR‐93‐5p         41.72        15.20         2.74          0.30    \<0.0001        0.0029
  *GNG4*                                                 35.42        4.39          8.07          hsa‐miR‐17‐5p         61.04        16.38         3.73          0.23    0.001           0.0388
                                                                                                  hsa‐miR‐20a‐5p        70.78        17.61         4.02          0.24    0.0004          0.025
                                                                                                  hsa‐miR‐20b‐5p        17.65        3.30          5.35          0.22    0.0014          0.0407
                                                                                                  hsa‐miR‐424‐3p        39.81        25.37         1.57          0.35    \<0.0001        0.009
                                                                                                  hsa‐miR‐501‐3p        7.07         2.95          2.39          0.23    0.0008          0.0326
                                                                                                  hsa‐miR‐663a          374.83       234.91        1.60          0.25    0.0008          0.0326
                                                                                                  hsa‐miR‐92a‐3p        121.60       41.18         2.95          0.34    \<0.0001        0.009
  *TNXB*                                                 23.48        134.34        0.17          hsa‐miR‐30a‐5p        2.38         4.61          0.52          0.25    0.0004          0.0444
                                                                                                  hsa‐miR‐497‐5p        1.77         7.12          0.25          0.30    \<0.0001        0.0271
  *IL7R*                                                 35.03        79.98         0.44          hsa‐miR‐150‐5p        14.90        39.17         0.38          0.32    \<0.0001        0.0271
                                                                                                  hsa‐miR‐650           4.51         16.60         0.27          0.26    \<0.0001        0.0271
  *YWHAG*                                                241.75       119.30        2.03          hsa‐miR‐21‐3p         22.68        9.89          2.29          0.27    \<0.0001        0.0116
                                                                                                  hsa‐miR‐221‐3p        13.53        4.12          3.28          0.29    \<0.0001        0.0116
                                                                                                  hsa‐miR‐27a‐3p        56.26        23.29         2.42          0.26    \<0.0001        0.0116
                                                                                                  hsa‐miR‐29b‐3p        24.31        9.83          2.47          0.24    0.0007          0.0438
  *PIK3CD*                                               27.33        46.48         0.59          hsa‐miR‐150‐5p        14.90        39.17         0.38          0.35    \<0.0001        0.0271
                                                                                                  hsa‐miR‐650           4.51         16.60         0.27          0.31    \<0.0001        0.0271
  ***BCL2***                                             24.42        62.11         0.39          hsa‐miR‐150‐5p        14.90        39.17         0.38          0.34    \<0.0001        0.0203
                                                                                                  hsa‐miR‐195‐5p        3.59         12.18         0.29          0.24    0.0003          0.0488
                                                                                                  **hsa‐miR‐203a**      12.52        3.70          3.38          −0.27   \<0.0001        0.0203
                                                                                                  hsa‐miR‐650           4.51         16.60         0.27          0.38    \<0.0001        0.0203
  *GNG7*                                                 3.66         22.76         0.16          hsa‐miR‐150‐5p        14.90        39.17         0.38          0.28    \<0.0001        0.0407
                                                                                                  hsa‐miR‐650           4.51         16.60         0.27          0.30    \<0.0001        0.0407
  *CHRM2*                                                2.32         4.20          0.55          hsa‐miR‐133b          1.71         6.94          0.25          0.36    \<0.0001        0.0271
                                                                                                  hsa‐miR‐145‐5p        132.97       223.14        0.60          0.35    \<0.0001        0.0271
  *F2R*                                                  51.19        25.16         2.03          hsa‐miR‐199a‐3p       44.83        22.53         1.99          0.28    0.0002          0.0326
                                                                                                  hsa‐miR‐199a‐5p       20.18        9.28          2.17          0.27    0.0004          0.0407
                                                                                                  hsa‐miR‐214‐3p        13.24        6.13          2.16          0.30    \<0.0001        0.0271
  ***THBS2***                                            212.12       32.95         6.44          hsa‐miR‐199a‐3p       44.83        22.53         1.99          0.35    \<0.0001        0.0081
                                                                                                  hsa‐miR‐214‐3p        13.24        6.13          2.16          0.42    \<0.0001        0.0081
                                                                                                  **hsa‐miR‐375**       20.50        54.53         0.38          −0.24   0.0005          0.0271
  ***GNG2***                                             13.93        29.33         0.47          **hsa‐miR‐203a**      12.52        3.70          3.38          −0.28   \<0.0001        0.0271
                                                                                                  hsa‐miR‐650           4.51         16.60         0.27          0.34    \<0.0001        0.0271

Bold text highlights negative beta coefficient between differential expression of miRNA and mRNA.
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Table [4](#mc22752-tbl-0004){ref-type="table-wrap"} shows associations between mRNA and miRNAs without seed‐region match, suggesting an indirect association between the miRNA and the mRNA, in that while miRNA and mRNA are associated, it is through the binding with other mRNA that influence the signaling pathway. In total there were 165 associations without seed‐region matches. Like those miRNA and mRNA with seed‐region matches, differential expression of most genes were associated with multiple miRNAs and miRNAs were associated with multiple genes. Several of the miRNAs that had seed‐region matches to the mRNA, such as let‐7i‐5p, were also associated with other genes, but without seed‐region matches. A summary of the miRNA and gene expression associations by seed‐region match can be seen in Table [5](#mc22752-tbl-0005){ref-type="table-wrap"}. Most miRNAs have both direct associations, supported by seed‐region matches, and indirect associations with pathway genes.

###### 

Associations between PI3K/AKT pathway genes with miRNAs that do not have a seed region match

  Gene name    Tumor mean   Normal mean   Fold change   miRNA             Tumor mean   Normal mean   Fold change   Raw *P*‐value   FDR *P*‐value
  ------------ ------------ ------------- ------------- ----------------- ------------ ------------- ------------- --------------- ---------------
  *BRCA*       87.46        35.35         2.47          hsa‐miR‐19b‐3p    29.80        10.42         2.86          0.0008          0.0383
                                                        hsa‐miR‐25‐3p     30.05        12.78         2.35          0.0002          0.0163
                                                        hsa‐miR‐425‐5p    11.76        6.97          1.69          0.001           0.0452
                                                        hsa‐miR‐650       4.51         16.60         0.27          0.0002          0.0163
                                                        hsa‐miR‐92a‐3p    121.60       41.18         2.95          0.0005          0.0291
  *PHLPP2*     79.32        139.85        0.57          hsa‐miR‐196b‐5p   17.89        5.53          3.24          \<0.0001        0.0271
  *TNC*        156.39       92.44         1.69          hsa‐let‐7i‐5p     62.16        39.97         1.56          \<0.0001        0.0163
                                                        hsa‐miR‐146b‐5p   4.46         2.67          1.67          0.0004          0.0296
                                                        hsa‐miR‐199a‐3p   44.83        22.53         1.99          \<0.0001        0.0163
                                                        hsa‐miR‐214‐3p    13.24        6.13          2.16          \<0.0001        0.0163
                                                        hsa‐miR‐21‐5p     463.11       167.37        2.77          0.0004          0.0296
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0163
  *HSP90AA1*   627.50       246.84        2.54          hsa‐miR‐203a      12.52        3.70          3.38          \<0.0001        0.0271
  *ITGB5*      110.37       68.02         1.62          hsa‐miR‐193b‐3p   9.12         5.42          1.68          \<0.0001        0.0163
                                                        hsa‐miR‐214‐3p    13.24        6.13          2.16          \<0.0001        0.0163
                                                        hsa‐miR‐365a‐3p   8.43         4.33          1.94          0.0007          0.0475
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0163
                                                        hsa‐miR‐99a‐5p    6.30         3.70          1.71          0.0006          0.0444
  *HSP90AB1*   593.22       213.90        2.77          hsa‐miR‐203a      12.52        3.70          3.38          \<0.0001        0.0271
                                                        hsa‐miR‐20a‐5p    70.78        17.61         4.02          0.0002          0.0326
                                                        hsa‐miR‐221‐3p    13.53        4.12          3.28          0.0002          0.0326
                                                        hsa‐miR‐6515‐5p   1.20         4.41          0.27          \<0.0001        0.0271
                                                        hsa‐miR‐663b      65.50        32.21         2.03          \<0.0001        0.0271
  *OSM*        6.68         2.31          2.90          hsa‐miR‐424‐3p    39.81        25.37         1.57          \<0.0001        0.0407
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0407
  *COMP*       9.53         1.45          6.57          hsa‐miR‐425‐5p    11.76        6.97          1.69          \<0.0001        0.0407
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0407
  *PIK3CG*     13.99        35.04         0.40          hsa‐miR‐150‐5p    14.90        39.17         0.38          \<0.0001        0.0203
  *COL1A1*     3190.86      754.73        4.23          hsa‐miR‐193b‐3p   9.12         5.42          1.68          0.0002          0.0233
                                                        hsa‐miR‐199a‐3p   44.83        22.53         1.99          0.0002          0.0233
                                                        hsa‐miR‐215       49.53        77.27         0.64          0.0007          0.0438
                                                        hsa‐miR‐375       20.50        54.53         0.38          0.0007          0.0438
  *YWHAE*      214.66       141.14        1.52          hsa‐miR‐424‐3p    39.81        25.37         1.57          0.0002          0.0407
  *CCND1*      317.79       122.64        2.59          hsa‐miR‐203a      12.52        3.70          3.38          0.0002          0.0244
                                                        hsa‐miR‐21‐5p     463.11       167.37        2.77          0.0006          0.0349
  *PDGFRB*     166.24       87.76         1.89          hsa‐miR‐199a‐3p   44.83        22.53         1.99          \<0.0001        0.0102
                                                        hsa‐miR‐199a‐5p   20.18        9.28          2.17          \<0.0001        0.0102
                                                        hsa‐miR‐199b‐5p   4.69         1.53          3.07          \<0.0001        0.0102
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0102
  *ITGA4*      36.27        71.10         0.51          hsa‐miR‐150‐5p    14.90        39.17         0.38          \<0.0001        0.0116
                                                        hsa‐miR‐650       4.51         16.60         0.27          \<0.0001        0.0116
  *YWHAH*      102.59       66.00         1.55          hsa‐miR‐650       4.51         16.60         0.27          \<0.0001        0.0163
  *LAMA5*      242.34       155.24        1.56          hsa‐miR‐17‐5p     61.04        16.38         3.73          \<0.0001        0.0203
                                                        hsa‐miR‐193b‐3p   9.12         5.42          1.68          \<0.0001        0.0203
                                                        hsa‐miR‐331‐3p    14.64        9.30          1.57          0.0002          0.0271
  *YWHAQ*      130.47       72.74         1.79          hsa‐miR‐19b‐3p    29.80        10.42         2.86          0.0002          0.0181
                                                        hsa‐miR‐21‐3p     22.68        9.89          2.29          0.0009          0.0471
                                                        hsa‐miR‐221‐3p    13.53        4.12          3.28          0.0002          0.0181
                                                        hsa‐miR‐25‐3p     30.05        12.78         2.35          \<0.0001        0.0116
                                                        hsa‐miR‐29a‐3p    110.29       51.04         2.16          0.0011          0.0471
                                                        hsa‐miR‐29b‐3p    24.31        9.83          2.47          0.001           0.0471
                                                        hsa‐miR‐3651      58.66        25.92         2.26          0.0006          0.0444
                                                        hsa‐miR‐92a‐3p    121.60       41.18         2.95          0.0011          0.0471
  *CDK4*       66.65        26.90         2.48          hsa‐miR‐17‐5p     61.04        16.38         3.73          \<0.0001        0.0271
                                                        hsa‐miR‐20a‐5p    70.78        17.61         4.02          \<0.0001        0.0271
                                                        hsa‐miR‐20b‐5p    17.65        3.30          5.35          0.0002          0.0407
                                                        hsa‐miR‐93‐5p     41.72        15.20         2.74          \<0.0001        0.0271
  *MYC*        181.11       49.00         3.70          hsa‐miR‐1246      629.21       412.81        1.52          0.0002          0.0163
                                                        hsa‐miR‐17‐5p     61.04        16.38         3.73          \<0.0001        0.0136
                                                        hsa‐miR‐19b‐3p    29.80        10.42         2.86          0.0002          0.0163
                                                        hsa‐miR‐20a‐5p    70.78        17.61         4.02          \<0.0001        0.0136
                                                        hsa‐miR‐20b‐5p    17.65        3.30          5.35          0.0002          0.0163
                                                        hsa‐miR‐3651      58.66        25.92         2.26          0.0003          0.0188
                                                        hsa‐miR‐375       20.50        54.53         0.38          \<0.0001        0.0136
                                                        hsa‐miR‐501‐3p    7.07         2.95          2.39          0.0003          0.0188
                                                        hsa‐miR‐583       6.61         3.22          2.05          0.0004          0.0233
                                                        hsa‐miR‐663a      374.83       234.91        1.60          0.0003          0.0188
                                                        hsa‐miR‐663b      65.50        32.21         2.03          \<0.0001        0.0136
                                                        hsa‐miR‐92a‐3p    121.60       41.18         2.95          \<0.0001        0.0136
  *ITGA11*     64.23        19.89         3.23          hsa‐miR‐199a‐3p   44.83        22.53         1.99          \<0.0001        0.0102
                                                        hsa‐miR‐199a‐5p   20.18        9.28          2.17          \<0.0001        0.0102
                                                        hsa‐miR‐199b‐5p   4.69         1.53          3.07          \<0.0001        0.0102
                                                        hsa‐miR‐214‐3p    13.24        6.13          2.16          \<0.0001        0.0102
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0102
                                                        hsa‐miR‐99a‐5p    6.30         3.70          1.71          0.0006          0.0136
  *ITGAV*      191.03       113.43        1.68          hsa‐miR‐1203      1.76         2.83          0.62          \<0.0001        0.0136
                                                        hsa‐miR‐1243      1.48         3.20          0.46          0.0005          0.0291
                                                        hsa‐miR‐199a‐5p   20.18        9.28          2.17          0.0003          0.0244
                                                        hsa‐miR‐204‐3p    0.92         2.37          0.39          0.0011          0.0244
                                                        hsa‐miR‐21‐3p     22.68        9.89          2.29          0.0009          0.0425
                                                        hsa‐miR‐21‐5p     463.11       167.37        2.77          0.0002          0.0203
                                                        hsa‐miR‐24‐3p     106.75       62.39         1.71          0.001           0.0425
                                                        hsa‐miR‐34a‐5p    25.15        12.32         2.04          0.0007          0.038
                                                        hsa‐miR‐4251      3.31         1.77          1.86          0.001           0.0425
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0136
  *PDGFC*      28.55        18.83         1.52          hsa‐miR‐99a‐5p    6.30         3.70          1.71          \<0.0001        0.0407
  *CREB3L1*    96.13        195.06        0.49          hsa‐miR‐193b‐3p   9.12         5.42          1.68          \<0.0001        0.0136
                                                        hsa‐miR‐375       20.50        54.53         0.38          \<0.0001        0.0136
                                                        hsa‐miR‐424‐3p    39.81        25.37         1.57          0.0005          0.0407
                                                        hsa‐miR‐6515‐5p   1.20         4.41          0.27          0.0002          0.0203
                                                        hsa‐miR‐92a‐3p    121.60       41.18         2.95          \<0.0001        0.0136
  *IL6R*       25.93        101.24        0.26          hsa‐miR‐19b‐3p    29.80        10.42         2.86          0.0002          0.0136
                                                        hsa‐miR‐203a      12.52        3.70          3.38          0.0007          0.0335
                                                        hsa‐miR‐221‐3p    13.53        4.12          3.28          0.0015          0.0488
                                                        hsa‐miR‐92a‐3p    121.60       41.18         2.95          \<0.0001        0.0136
  *COL6A3*     893.58       541.26        1.65          hsa‐miR‐193b‐3p   9.12         5.42          1.68          \<0.0001        0.0081
                                                        hsa‐miR‐199a‐3p   44.83        22.53         1.99          \<0.0001        0.0081
                                                        hsa‐miR‐199a‐5p   20.18        9.28          2.17          \<0.0001        0.0081
                                                        hsa‐miR‐199b‐5p   4.69         1.53          3.07          \<0.0001        0.0081
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0081
  *ITGA2*      206.67       82.69         2.50          hsa‐miR‐1291      5.52         3.67          1.51          0.0009          0.0318
                                                        hsa‐miR‐19b‐3p    29.80        10.42         2.86          \<0.0001        0.0081
                                                        hsa‐miR‐23a‐3p    174.68       87.53         2.00          0.0002          0.0116
                                                        hsa‐miR‐27a‐3p    56.26        23.29         2.42          \<0.0001        0.0081
                                                        hsa‐miR‐34a‐5p    25.15        12.32         2.04          \<0.0001        0.0081
                                                        hsa‐miR‐650       4.51         16.60         0.27          0.0002          0.0116
                                                        hsa‐miR‐663b      65.50        32.21         2.03          0.0019          0.0116
                                                        hsa‐miR‐92a‐3p    121.60       41.18         2.95          0.0004          0.0116
  *COL1A2*     1838.76      588.95        3.12          hsa‐miR‐199a‐5p   20.18        9.28          2.17          \<0.0001        0.0116
                                                        hsa‐miR‐199b‐5p   4.69         1.53          3.07          \<0.0001        0.0116
                                                        hsa‐miR‐214‐3p    13.24        6.13          2.16          \<0.0001        0.0116
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0116
  *YWHAB*      389.26       223.04        1.75          hsa‐let‐7i‐5p     62.16        39.97         1.56          0.0022          0.0176
                                                        hsa‐miR‐151a‐3p   5.15         1.56          3.31          \<0.0001        0.0029
                                                        hsa‐miR‐15a‐5p    7.69         5.07          1.52          0.0002          0.0048
                                                        hsa‐miR‐193b‐3p   9.12         5.42          1.68          0.0036          0.0234
                                                        hsa‐miR‐199a‐5p   20.18        9.28          2.17          0.0057          0.0113
                                                        hsa‐miR‐199b‐5p   4.69         1.53          3.07          0.0023          0.0311
                                                        hsa‐miR‐21‐5p     463.11       167.37        2.77          0.0002          0.0048
                                                        hsa‐miR‐221‐3p    13.53        4.12          3.28          \<0.0001        0.0029
                                                        hsa‐miR‐23a‐3p    174.68       87.53         2.00          0.0005          0.0083
                                                        hsa‐miR‐25‐3p     30.05        12.78         2.35          \<0.0001        0.0029
                                                        hsa‐miR‐29a‐3p    110.29       51.04         2.16          \<0.0001        0.0029
                                                        hsa‐miR‐29b‐3p    24.31        9.83          2.47          \<0.0001        0.0029
                                                        hsa‐miR‐34a‐5p    25.15        12.32         2.04          0.0005          0.0083
                                                        hsa‐miR‐361‐5p    11.62        6.20          1.87          0.001           0.0113
                                                        hsa‐miR‐424‐3p    39.81        25.37         1.57          \<0.0001        0.0029
                                                        hsa‐miR‐425‐5p    11.76        6.97          1.69          0.0007          0.0095
                                                        hsa‐miR‐4749‐3p   8.01         12.04         0.67          0.0027          0.0191
                                                        hsa‐miR‐663a      374.83       234.91        1.60          0.0056          0.0311
                                                        hsa‐miR‐663b      65.50        32.21         2.03          \<0.0001        0.0029
                                                        hsa‐miR‐92a‐3p    121.60       41.18         2.95          \<0.0001        0.0029
  *GNG4*       35.42        4.39          8.07          hsa‐miR‐3651      58.66        25.92         2.26          0.0008          0.0326
                                                        hsa‐miR‐663b      65.50        32.21         2.03          \<0.0001        0.009
  *TNXB*       23.48        134.34        0.17          hsa‐miR‐133b      1.71         6.94          0.25          \<0.0001        0.0271
                                                        hsa‐miR‐145‐5p    132.97       223.14        0.60          \<0.0001        0.0271
                                                        hsa‐miR‐365a‐3p   8.43         4.33          1.94          0.0008          0.0458
                                                        hsa‐miR‐3976      2.97         1.24          2.39          0.0006          0.0444
                                                        hsa‐miR‐99a‐5p    6.30         3.70          1.71          0.0009          0.0458
  *IL7R*       35.03        79.98         0.44          hsa‐miR‐203a      12.52        3.70          3.38          \<0.0001        0.0271
  *YWHAG*      241.75       119.30        2.03          hsa‐miR‐106b‐5p   15.90        5.19          3.06          \<0.0001        0.0116
                                                        hsa‐miR‐17‐5p     61.04        16.38         3.73          \<0.0001        0.0116
                                                        hsa‐miR‐19b‐3p    29.80        10.42         2.86          0.0004          0.0362
                                                        hsa‐miR‐20a‐5p    70.78        17.61         4.02          0.0002          0.0203
                                                        hsa‐miR‐20b‐5p    17.65        3.30          5.35          0.0008          0.0465
                                                        hsa‐miR‐21‐5p     463.11       167.37        2.77          0.0006          0.0116
                                                        hsa‐miR‐25‐3p     30.05        12.78         2.35          \<0.0001        0.0438
                                                        hsa‐miR‐3651      58.66        25.92         2.26          0.0006          0.0438
                                                        hsa‐miR‐650       4.51         16.60         0.27          0.0007          0.0438
                                                        hsa‐miR‐93‐5p     41.72        15.20         2.74          \<0.0001        0.0116
  *BCL2L1*     144.28       64.05         2.25          hsa‐miR‐92a‐3p    121.60       41.18         2.95          \<0.0001        0.0407
  *CD19*       3.78         7.59          0.50          hsa‐miR‐150‐5p    14.90        39.17         0.38          \<0.0001        0.0407
  *F2R*        51.19        25.16         2.03          hsa‐let‐7i‐5p     62.16        39.97         1.56          0.0003          0.0407
                                                        hsa‐miR‐146b‐5p   4.46         2.67          1.67          0.0004          0.0407
                                                        hsa‐miR‐193b‐3p   9.12         5.42          1.68          0.0002          0.0326
                                                        hsa‐miR‐199b‐5p   4.69         1.53          3.07          \<0.0001        0.0271
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0271
  *THBS2*      212.12       32.95         6.44          hsa‐let‐7i‐5p     62.16        39.97         1.56          0.0003          0.0203
                                                        hsa‐miR‐193b‐3p   9.12         5.42          1.68          \<0.0001        0.0081
                                                        hsa‐miR‐199a‐5p   20.18        9.28          2.17          \<0.0001        0.0081
                                                        hsa‐miR‐199b‐5p   4.69         1.53          3.07          \<0.0001        0.0081
                                                        hsa‐miR‐934       4.36         0.94          4.66          \<0.0001        0.0081
  *GNG2*       13.93        29.33         0.47          hsa‐miR‐150‐5p    14.90        39.17         0.38          \<0.0001        0.0271
  *LPAR1*      12.91        46.29         0.28          hsa‐miR‐21‐5p     463.11       167.37        2.77          \<0.0001        0.0407
                                                        hsa‐miR‐497‐5p    1.77         7.12          0.25          \<0.0001        0.0407
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###### 

Associations between miRNAs and mRNA expression based on seed region matches

  miRNA             mRNA associated with a seed match                                                   mRNA associated without seed region match
  ----------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------
  hsa‐let‐7i‐5p     *ITGAV, COL6A3, COL1A2*                                                             *TNC, YWHAB, F2R, THBS2*
  hsa‐miR‐10a‐5p    *ITGA2*                                                                             
  hsa‐miR‐106b‐5p   *CCND1, YWHAQ, ITGA2, YWHAB*                                                        *YWHAG*
  hsa‐miR‐1203                                                                                          *ITGAV*
  hsa‐miR‐1243                                                                                          *ITGAV*
  hsa‐miR‐1246      *BRCA1, YWHAB*                                                                      *MYC*
  hsa‐miR‐1291                                                                                          *ITGA2*
  hsa‐miR‐130b‐3p   *YWHAB*                                                                             
  hsa‐miR‐133b      *CHRM2*                                                                             *TNXB*
  hsa‐miR‐145‐5p    ***BRCA1*** [^a^](#mc22752-note-0002){ref-type="fn"} *IGF1, PDGFRA, THBS1, CHRM2*   *TNXB*
  hsa‐miR‐146b‐5p                                                                                       *TNC, F2R*
  hsa‐miR‐150‐5p    *PHLPP2, PDGFRA, IL6R, IL7R, PIK3CD, BCL2, GNG7*                                    *PIK3CG, ITGA4, CD19, GNG2*
  hsa‐miR‐151a‐3p                                                                                       *YWHAB*
  hsa‐miR‐15a‐5p                                                                                        *YWHAB*
  hsa‐miR‐17‐5p     *BRCA1, CCND1, YWHAQ, **PDGFRA**, **IL6R**, ITGA2, YWHAB*,                          *LAMA5, CDK4, MYC, YWHAG*
  hsa‐miR‐193b‐3p   *PDGFRB, ITGA11, COL1A2*                                                            *ITGB5, COL1A1, LAMA5, CREB3L1, COL6A3, YWHAB, F2R, THBS2*
  hsa‐miR‐195‐5p    *BCL2*                                                                              
  hsa‐miR‐196a‐5p   *YWHAB*                                                                             
  hsa‐miR‐196b‐5p   ***SGK2***, ***CREB3L1***, *YWHAB*                                                  *PHLPP2*
  hsa‐miR‐199a‐3p   *ITGB5, ITGAV, COL1A2, YWHAB, F2R, THBS2*                                           *TNC,COL1A1, PDGFRB, ITGA11, COL6A3*
  hsa‐miR‐199a‐5p   *TNC, ITGB5, COL1A1, F2R*                                                           *PDGFRB, ITGA11, ITGAV, COL6A3, COL1A2, YWHAB, THBS2*
  hsa‐miR‐199b‐5p   *TNC, ITGB5, COL1A1, PDGFC*                                                         *PDGFRB, ITGA11, COL6A3, COL1A2, YWHAB, F2R, THBS2*
  hsa‐miR‐19b‐3p    *CCND1, **PDGFRA**, YWHAB*                                                          *BRCA1, YWHAQ, MYC, IL6R, ITGA2, YWHAG*
  hsa‐miR‐203a      ***PIK3CG***, ***ITGA4***, ***PDGFRA***, *ITGA2*, ***BCL2***, ***GNG2***            *HSP90AA1, HSP90AB1, CCND1, IL6R, IL7R*
  hsa‐miR‐204‐3p                                                                                        *ITGAV*
  hsa‐miR‐20a‐5p    *BRCA1, CCND1, YWHAQ, **PDGFRA**, **IL6R**, ITGA2, YWHAB, GNG4*                     *HSP90AB1, CDK4, MYC, YWHAG*
  hsa‐miR‐20b‐5p    *BRCA1, CCND1, YWHAQ, **PDGFRA**,**IL6R**, ITGA2, YWHAB, GNG4*                      *CDK4, MYC, YWHAG*
  hsa‐miR‐2117      *IL6R*                                                                              
  hsa‐miR‐21‐3p     *YWHAB, YWHAG*                                                                      *YWHAQ, ITGAV*
  hsa‐miR‐21‐5p     ***IL6R***, *ITGA2*                                                                 *TNC, CCND1, ITGAV, YWHAB, YWHAG, LPAR1'*
  hsa‐miR‐214‐3p    ***PHLPP1***, *COL1A1*, *PDGFRB*, *ITGAV*, *COL6A3*, *F2R*, *THBS2*                 *TNC, ITGB5, ITGA11, COL1A2*
  hsa‐miR‐215                                                                                           *COL1A1*
  hsa‐miR‐221‐3p    *CCND1, ITGA2, YWHAG*                                                               *HSP90AB1, YWHAQ, IL6R, YWHAB*
  hsa‐miR‐23a‐3p    *ITGAV, **IL6R***                                                                   *ITGA2, YWHAB*
  hsa‐miR‐24‐3p     *ITGB5, ITGA2, YWHAB*                                                               *ITGAV*
  hsa‐miR‐25‐3p                                                                                         *BRCA1, YWHAQ, YWHAB*
  hsa‐miR‐27a‐3p    *CCND1, YWHAQ, ITGAV, **IL6R**, YWHAB, YWHAG*                                       *ITGA2*
  hsa‐miR‐29a‐3p    *ITGA2*                                                                             *YWHAQ, YWHAB*
  hsa‐miR‐29b‐3p    *CCND1, **PDGFRA**, ITGA2, YWHAG*                                                   *YWHAQ, YWHAB*
  hsa‐miR‐30a‐5p    *TNXB*                                                                              
  hsa‐miR‐32‐3p     *YWHAB*                                                                             
  hsa‐miR‐331‐3p                                                                                        *LAMA5*
  hsa‐miR‐34a‐5p                                                                                        *ITGAV, ITGA2, YWHAB*
  hsa‐miR‐361‐5p                                                                                        *YWHAB*
  hsa‐miR‐365a‐3p                                                                                       *ITGB5, TNXB*
  hsa‐miR‐3651      *CDK4, **IL6R**, ITGA2, YWHAB*                                                      *YWHAQ, MYC, GNG4, YWHAG*
  hsa‐miR‐375       ***YWHAB***, ***THBS2***                                                            *COL1A1, MYC, CREB3L1*
  hsa‐miR‐3976                                                                                          *TNXB*
  hsa‐miR‐424‐3p    *GNG4*                                                                              *YWHAB,OSM, YWHAE, CREB3L1*,
  hsa‐miR‐425‐5p    *YWHAQ*                                                                             *BRCA1, YWHAB*
  hsa‐miR‐4251                                                                                          *ITGAV*
  hsa‐miR‐4749‐3p                                                                                       *YWHAB*
  hsa‐miR‐497‐5p    *TNXB*                                                                              *LPAR1*
  hsa‐miR‐501‐3p    ***PDGFRA***, *ITGA2*, *YWHAB*, *GNG4*                                              *MYC*
  hsa‐miR‐518c‐5p   *IL6R*                                                                              
  hsa‐miR‐583                                                                                           *MYC*
  hsa‐miR‐6071      ***ITGAV***                                                                         
  hsa‐miR‐650       *PIK3CG, PDGFRA, IL6R, IL7R, PIK3CD, BCL2, GNG7, GNG2*                              *BRCA1, ITGA4, YWHAH, ITGA2, YWHAG*
  hsa‐miR‐6515‐5p   ***YWHAB***                                                                         *HSP90AB1, CREB3L1*
  hsa‐miR‐663a      *GNG4*                                                                              *MYC, ITGA2, YWHAB*
  hsa‐miR‐663b      ***PHLPP1***                                                                        *HSP90AB1, MYC, YWHAB, GNG4*
  hsa‐miR‐92a‐3p    *GNG4*                                                                              *BRCA1, YWHAQ, MYC, CREB3L1, IL6R, ITGA2, YWHAB, BCL2L1*
  hsa‐miR‐934       *COL1A1, PDGFC*                                                                     *TNC, OSM, PDGFRB, ITGA11, COL6A3, COL1A2, F2R, THBS2*
  hsa‐miR‐93‐5p     *BRCA1, CCND1,YWHAQ, ITGA2, YWHAB*                                                  *ITGB5, CDK4, YWHAG*
  hsa‐miR‐99a‐5p                                                                                        *ITGB5, ITGA11, PDGFC, TNXB*

Bold text indicates an inverse direction of association.

© 2017 Wiley Periodicals, Inc.

4. DISCUSSION {#mc22752-sec-0012}
=============

The PI3K/Akt‐signaling pathway is frequently activated in cancer. Of the 304 genes evaluated 133 (43.8%) had FC differences that were \<0.67 or \>1.50, which is slightly higher than the rate of dysregulated genes for all protein‐coding genes (37.5%). Forty‐seven of the 133 dysregulated genes were associated with miRNA expression. For those mRNA and miRNAs with a seed region match, 26 were inversely associated suggesting a greater likelihood of a direct association. Several genes within this signaling pathway have become therapeutic targets, thus a better understanding of the PI3K/Akt‐signaling pathway can provide insight into the underlying biology associated with these targets.

During cellular stress, as in oncogenesis, the PI3K/Akt‐signaling pathway is a key regulator of cell survival.[26](#mc22752-bib-0026){ref-type="ref"} PI3K can be divided into two major subclasses that have been associated with cancer.[4](#mc22752-bib-0004){ref-type="ref"} Subclass IA is activated by receptors with a protein tyrosine kinase (RPTK) activity; hormones, cytokines, growth factors, insulin receptors activate the subclass IA. The IB subclass of PI3Ks is activated by receptors coupled with G proteins (GPCR). In this signaling pathway AKTs are key intermediates. There are three AKTs, amplification of AKT2 has been detected in colorectal tumors and has been positively associated with tumor aggressiveness.[2](#mc22752-bib-0002){ref-type="ref"}, [27](#mc22752-bib-0027){ref-type="ref"} In our data AKT2 was significantly up‐regulated, although the FC was modest (FC = 1.15). Amplification of AKTs, alters several downstream molecules including mTOR, MYC, eukaryotic initiation factor of translation (eIF4E), IKK, cyclin D1, CREB, CASP9, and BAD. Both BAD and CASP9 were down‐regulated in our data (FC of 0.71 and 0.74, respectively) and MYC and cyclin D1 were up‐regulated (FC 3.70 and 2.59, respectively) as could be expected when AKT2 would be up‐regulated.[28](#mc22752-bib-0028){ref-type="ref"} PTEN is a negative regulator of the PI3K/Akt‐signaling pathway and was significantly down‐regulated, although the FC was modest (FC = 0.83). Many of the expression levels that we observed are consistent with an activated PI3K/Akt‐signaling pathway that would promote tumorigenesis.

Several parts of the PI3K/Akt‐signaling pathway appear to have dysregulated genes. Most major junctures in the pathway had both up and down‐regulated genes. One example are the genes and receptors associated with extracellular matrix integrity including collagen genes *COL1A1*, *COL1A2*, and *COL4A1* that were significantly up‐regulated with strong FCs (FC 4.32, 3.12, and 2.09, respectively) while other collagen genes were down‐regulated (Supplemental Table S2 list all genes analyzed and FCs). Tenascin genes involved in cell to matrix interaction and extracellular matrix formation were down‐regulated (*TNN* FC 0.67, *TNXB* FC 0.17, and *TNC* FC 1.69) as were the integrin genes, which are extracellular matrix receptors for collagens and related proteins (*ITGA11* FC 3.23, *ITGA2* FC 2.50, *ITGA2B* FC 0.62, *ITGA4* FC 0.51, *ITGA8* FC 0.26, and *ITGAV* FC 1.68). The PI3K genes also showed both up and down‐regulation, such as *PIK3CA* with a FC of 1.22, *PIK3CD* FC 0.59, and *PIK3CG* FC 0.40. The ultimate impact of these genes on tumorigenesis, may depend on the balance of up‐ and down‐regulation and how it enables cells to survive and grow.

Several miRNAs have previously been associated with genes in the PI3K/Akt‐signaling pathway.[13](#mc22752-bib-0013){ref-type="ref"} In the study by Josse and colleagues, the PI3K/Akt‐signaling pathway was one of the top pathways associated with dysregulated miRNA expression levels.[13](#mc22752-bib-0013){ref-type="ref"} MiRNAs identified as being important to this signaling pathway were miR‐143, miR‐145, miR‐133a, and miR‐223. We only identified miR‐145‐5p as being associated with *BRCA1, IGF1, PDGFRA, THBS1, CHRM2*, and *TNXB*. Other miRNAs associated previously with genes in PI3K/Akt‐signaling pathway include miR‐590‐5p, 106b, and miR‐93 with *PTEN*,[29](#mc22752-bib-0029){ref-type="ref"}, [30](#mc22752-bib-0030){ref-type="ref"} miR‐497 with IGF1R,[31](#mc22752-bib-0031){ref-type="ref"} miR‐451 with *LKB1, AKT, PI3K*, and *BCL2*,[32](#mc22752-bib-0032){ref-type="ref"} and miR‐126 with *AKT*.[33](#mc22752-bib-0033){ref-type="ref"} We observed associations between miR‐497 and miR‐106b‐5p with various genes in the pathway. Differences between our study and the literature in detection of associations result from our focusing on those genes with higher FCs. Thus we did not assess genes with lower FC, such as *AKT* and *PTEN*, with miRNAs.

We utilized seed‐region matches to identify miRNAs that were more likely to have a direct effect on the mRNA, leading to mRNA degradation from the miRNA binding with the 3′UTR of the mRNA. Those matches that were most likely to have a direct effect were the 26 matches where the expression of the miRNA was opposite that of the mRNA expression. Indirect effects are most likely operating feedback and feed‐forward loops.[34](#mc22752-bib-0034){ref-type="ref"}, [35](#mc22752-bib-0035){ref-type="ref"}, [36](#mc22752-bib-0036){ref-type="ref"} In feedback loops, regulators such as miRNAs and transcription factors (TFs) can have either the same effect (repression of expression) or opposite effects where the TF enhances the mRNA on each other.[35](#mc22752-bib-0035){ref-type="ref"} In feed‐forward loops, TF regulates the miRNA as well as a target gene (TG), which is in turn also regulated by the miRNA. In this instance, the miRNA may regulate the TG directly, through seed region binding leading to mRNA degradation or translational repression, or indirectly, through repression of the TF that is influencing transcription of the same TG. It has been suggested that regulatory paths involving miRNAs are prevalent mechanisms of gene expression.[35](#mc22752-bib-0035){ref-type="ref"} Studies have shown that genes can share a regulatory network with miR‐150‐5p via feed forward loops.[34](#mc22752-bib-0034){ref-type="ref"} As this miRNA was only associated with mRNAs with a positive beta coefficient, even when seed‐region matches were identified, it is possible that this miRNA is involved in feed‐forward loops in CRC.

Of the 26 mRNA:miRNA significant inverse association, both *IL6R* and *PDGFRA* were associated with seven miRNAs. Both of these genes stimulate Class IA PI3Ks that in turn alter AKT. Both of these genes were associated with multiple miRNAs in the miR‐17 to miR‐92 cluster, including miR‐17‐5p, miR‐19b‐3p, miR‐20a‐5p, miR‐20b‐5p, miR‐29b, miR‐27a‐3p, and miR‐23a‐3p. Overexpression of miR‐17‐5p has been shown to inhibit proliferation and trigger apoptosis.[37](#mc22752-bib-0037){ref-type="ref"} MiR‐20 has previously been associated with cyclin D1[38](#mc22752-bib-0038){ref-type="ref"} and has been shown to be associated with vascular endothelial growth factor, a cytokine, via activation of Akt signaling.[39](#mc22752-bib-0039){ref-type="ref"} MiR‐27a‐3p has been shown to promote cell proliferation and invasion possibly through its association with the cytokine *TRAIL* (TNF‐related apoptosis‐inducing ligand)[40](#mc22752-bib-0040){ref-type="ref"} or through its effects on insulin.[41](#mc22752-bib-0041){ref-type="ref"} *IL6R* differential expression also was inversely associated with miR‐21‐5p suggesting a direct association between this mRNA and miRNA. MiR‐21 has been previously linked to increased inflammation and has been shown to promote Akt signaling and exert an anti‐apoptotic effect.[42](#mc22752-bib-0042){ref-type="ref"} Other miRNA:miRNAs that had a greater potential for a direct effect given the inverse association between the miRNA and the mRNAs that stimulated Class IA PI3Ks were miR‐203a, miR‐375 and miR‐607a through their inverse association with *ITGA4*, *ITGAV*, and *THBS2*. These direct associations also would impact the Class IA PI3Ks that could lead to indirect effects with other miRNA:mRNA associations. MiR‐203a was inversely association with both *PIK3CG* and *GNG2* expression, again suggesting a direct association that would operate at the stimulate component of the pathway. Up‐regulation of miR‐203 has been shown to inhibit proliferation and metastasis in CRC.[43](#mc22752-bib-0043){ref-type="ref"} These associations could serve as key targets for future research.

Several miRNAs may be important given the frequent number of associated genes both with and without seed‐region matches although associations do not any miRNA:mRNAs with inverse associations. These include miR‐150‐5p, miR‐199a‐3p, miR‐199a‐5p, and miR‐199b‐5p with 11 mRNAs, miR‐650 with 13 mRNAs, and miR‐93‐5p with 7 mRNAs. MiR‐150 has been shown to impair inflammatory cytokine production[44](#mc22752-bib-0044){ref-type="ref"}; ITGA3 has previously been associated with the anti‐tumor miR‐199 family. Over‐expression of miR‐93 has been shown to promote tumorigenesis and metastasis by activating the PI3K/Akt‐signaling pathway.[45](#mc22752-bib-0045){ref-type="ref"} *YWHAB* (14‐3‐3 proteinβ) was associated with 19 miRNA seed‐region matches, two of which had inverse associations, miR‐375 and miR‐6515‐5p.

Although our sample size is small, it is one of the largest available containing samples with paired carcinoma and normal mucosa data. While normal colonic mucosa may not be truly "normal," it is the closest normal mucosa that can be used for a matched‐paired analysis. Normal colonic mucosa was taken from the same colonic site as the tumor to prevent differences in expression from being the result of tumor location. The same RNA prep was used to generate both miRNA and mRNA data, which could minimize differences in tissue samples that could contribute to associations. We focused only on those genes that were statistically significant and also had a FC of 1.5 or greater or 0.67 or less. Using these criteria, we did not examine all statistically significant genes and miRNAs that were differentially expressed. Thus, genes like *PIK3CA*, which were statistically significantly dysregulated but the FC was 1.22 and *PTEN* with a FC of 0.83, were not examined further with miRNAs. A biologically important FC is not well defined, and by using set values for further follow‐up we could have missed genes associated with miRNAs. Additionally, in our current analysis, we utilized a negative binomial model with a random subject effect. Other statistical methods based on fixed effect models such as DESEQ2 could have slightly different results. We exclusively used the KEGG pathway database to identify signaling pathway genes. Thus, other genes not identified in KEGG may importantly alter PI3K/Akt‐signaling as well as influence miRNA expression. When evaluating miRNA with mRNAs, we could have further missed important associations since miRNAs have their impact post‐transcriptionally. However, much of the current information on miRNA target genes comes from gene expression data and associations observed may have important biological meaning, but must be acknowledged as being incomplete.[24](#mc22752-bib-0024){ref-type="ref"}, [46](#mc22752-bib-0046){ref-type="ref"}

In conclusion, we find the PI3K/Akt‐signaling pathway is dysregulated in CRC and that several of the dysregulated genes are associated with miRNAs. Several of these associations involve negative beta coefficients and seed‐region matches between the miRNA and mRNA, suggesting that these miRNAs directly repress gene expression, and thus alter PI3K/Akt signaling; other associations we identified may be downstream effects resulting from the pathways disruption. These results need to be confirmed in other CRC studies, including laboratory‐based setting. Given the prominence of the PI3K/Akt‐signaling pathway in the carcinogenic process, it is important to obtain a better understanding of the underlying genomics of this pathway in an effort to help identify and refine therapeutic agents.
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